UAB Med Cast
UAB Med Cast
Brain Tumor Therapy
Loading
/
  • LISTEN ON:
  • Listen on Spotify
  • Listen on iHeart
  • Listen on Apple Podcasts
  • Listen on Google Podcasts
  • Listen on TuneIn
  • Listen on Stitcher
  • Subscribe via RSS
Placeholder Ad
Placeholder Ad
Placeholder Ad
Placeholder Ad

Brain Tumor Therapy

Show: (May 23, 2022)

brain-tumor-therapy

Immunotherapy is the most promising avenue of research for treating deadly brain tumors. M. R. Chambers, DVM, MD, and James Markert, MD, MPH, are leading clinical trial research on therapies using oncolytic viruses and checkpoint inhibitors as part of an ongoing NIH-awarded UAB Specialized Program of Research. They discuss the promising immune system responses they have seen in humans and dogs via RNA-seq and NanoString analyses, as well as how results may translate from one species to the other in the form of expanded clinical trials.

Top Three Options for Breast Reconstruction

Immunotherapy is the most promising avenue of research for treating deadly brain tumors. M. R. Chambers, DVM, MD, and James ...

Listen

Multidisciplinary Consensus in Diagnosis and Treatment Options of Spontaneous Intracranial Hypotension

Immunotherapy is the most promising avenue of research for treating deadly brain tumors. M. R. Chambers, DVM, MD, and James ...

Listen

Innovative Robotic Coronary Artery Bypass (CABG) Surgery Offers Patients Faster Recovery

Immunotherapy is the most promising avenue of research for treating deadly brain tumors. M. R. Chambers, DVM, MD, and James ...

Listen

Left Atrial Appendage Occlusion Devices and Procedures

Immunotherapy is the most promising avenue of research for treating deadly brain tumors. M. R. Chambers, DVM, MD, and James ...

Listen

Multi-Disciplinary Hepatocellular Carcinoma Clinic (HCC)

Immunotherapy is the most promising avenue of research for treating deadly brain tumors. M. R. Chambers, DVM, MD, and James ...

Listen

The Intricate Nature of Head and Neck Cancer Surgery

Immunotherapy is the most promising avenue of research for treating deadly brain tumors. M. R. Chambers, DVM, MD, and James ...

Listen

Degenerative Mitral Valve Disease

Immunotherapy is the most promising avenue of research for treating deadly brain tumors. M. R. Chambers, DVM, MD, and James ...

Listen

Undiagnosed Diseases Program: Finding Answers in Mysterious Conditions

Immunotherapy is the most promising avenue of research for treating deadly brain tumors. M. R. Chambers, DVM, MD, and James ...

Listen

Mechanical Thrombectomy for Stroke

Immunotherapy is the most promising avenue of research for treating deadly brain tumors. M. R. Chambers, DVM, MD, and James ...

Listen

Using Telehealth to Improve Access to Trauma Care Among Injured Rural Patients in the US

Immunotherapy is the most promising avenue of research for treating deadly brain tumors. M. R. Chambers, DVM, MD, and James ...

Listen